Latest

Aug 05, 2017
Pharmaceutical Executive
For the life sciences industry in 2017, engaging across social media means less talking—and more listening. Peter Houston reports.
Jul 26, 2017
Pharma companies have been protesting expansion of the federal program that provides deeply discounted prescription drugs to certain hospitals and health providers serving low-income, uninsured patients.
Jul 16, 2017
Pharmaceutical Executive
Outlining the four core elements pharma companies need to lay the foundation for a solid digital health infrastructure.
Jul 15, 2017
Mary Ann Slack and Mitra Rocca outline how FDA is adopting electronic practices and initiating efforts to simplify the submission process for new drug and generic drug applications.
Jul 07, 2017
Pharmaceutical Executive
David Keane outlines four best practices in implementing AI-based technology to help achieve physician-engagement wins.
Jun 20, 2017
There is a tremendous, untapped market of undiagnosed patients for a variety of conditions, writes John Pagliuca. But how do you identify them when they are essentially hidden from view through conventional means?
Jun 20, 2017
Most challenges boil down to two simple categories: "complicated" and "complex". Knowing how to categorize each problem is key to solving it, writes Steve Figman.
Jun 11, 2017
Jackie DeAngelis outlines three common mistakes that hinder access attainment when launching a new drug.
Jun 08, 2017
Pharmaceutical Executive
In the 21st Century Cures Act, Congress excluded from FDA regulation certain clinical decision support, or CDS, software.
May 12, 2017
The absence of pharma brands on social media creates a significant void of reputable healthcare information to aid patients, writes Dawn Lacallade.
native1_300x100
lorem ipsum